mammary cancer
breast cancer cells
Fate of mammary stem cells
fate of MSC
breast cancer biology
tumor growth
tumor phenotype
origin of tumor heterogeneity
resulting tumor heterogeneity
transformation of MSC
expression of PIK3CA mutations
panel of PI3K inhibitors
differentiation of MSC
drug-resistance
new mouse model of breast cancer
mammary tissue homeostasis
conditional expression of PIK3CA hotspot mutations
clinical implications
Clinical investigation
clinical reports
resistance mechanisms
trigger formation of stem
molecular portrait
promotion of transformation
oncogenic event
oncogenic perturbation
models of drug
better therapies
preclinical studies
early molecular events responsible
tumorigenesis
combination of standard chemotherapy
challenging questions
gene coding
pathway
proliferation
contribution
H1047R
example
situ genetic lineage tracing
kinase
eventual progression
metastasis
E545K
Procr
therapy failure
catalytic subunit
study
hypothesis
novel targets
biomarkers
unbiased approaches
knowledge
patients
Accumulating evidence
Phosphoinositide
tumors